Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures [Phase 4]

View source ↗

Summary

Phase 4 study evaluating perampanel as monotherapy in untreated participants with focal onset seizures (with or without focal to bilateral tonic-clonic seizures…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED